NATHAN CLINTON: Open Payments
NPI 1801180005 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 47 payments from 12 companies in 2025. Trend: 2023 $387 · 2024 $431 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| ABBVIE INC. | 6 | $86 |
| Lilly USA, LLC | 4 | $74 |
| PFIZER INC. | 3 | $49 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: Wegovy, CAPLYTA, MOUNJARO, VRAYLAR, Ozempic, JARDIANCE, Cologuard Collection Kit, XIFAXAN.
Industry payments across OH — which companies pay providers there.
